CY1117011T1 - Παραγωγα αζολιου - Google Patents
Παραγωγα αζολιουInfo
- Publication number
- CY1117011T1 CY1117011T1 CY20151101118T CY151101118T CY1117011T1 CY 1117011 T1 CY1117011 T1 CY 1117011T1 CY 20151101118 T CY20151101118 T CY 20151101118T CY 151101118 T CY151101118 T CY 151101118T CY 1117011 T1 CY1117011 T1 CY 1117011T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutically acceptable
- acceptable salts
- azoli
- producers
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 abstract 1
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Παρέχονται νέες ενώσεις που συνδέονται προς FKBP12 ή φαρμακευτικώς αποδεκτά άλατα αυτών, καθώς επίσης νέες θεραπευτικές χρήσιμες για πρόληψη ή θεραπεία αλωπεκίας που περιλαμβάνουν αυτές τις ενώσεις ή φαρμακευτικώς αποδεκτά άλατα αυτών. Ειδικώς, παρέχονται ενώσεις που αντιπροσωπεύονται με τον τύπο (1) [όπου R1 αντιπροσωπεύει έναν από τους μετέπειτα τύπους (2) ή (3)] ή φαρμακευτικώς αποδεκτά άλατα αυτών.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011056149 | 2011-03-15 | ||
| EP12757646.0A EP2687524B1 (en) | 2011-03-15 | 2012-03-15 | Azole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117011T1 true CY1117011T1 (el) | 2017-04-05 |
Family
ID=46830815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151101118T CY1117011T1 (el) | 2011-03-15 | 2015-12-08 | Παραγωγα αζολιου |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9181229B2 (el) |
| EP (1) | EP2687524B1 (el) |
| JP (1) | JP5828339B2 (el) |
| KR (1) | KR101854949B1 (el) |
| CN (1) | CN103502240B (el) |
| AU (1) | AU2012229834B2 (el) |
| BR (1) | BR112013022710A2 (el) |
| CA (1) | CA2829746C (el) |
| CY (1) | CY1117011T1 (el) |
| DK (1) | DK2687524T3 (el) |
| ES (1) | ES2549559T3 (el) |
| HK (1) | HK1189580A1 (el) |
| HR (1) | HRP20151062T1 (el) |
| HU (1) | HUE027055T2 (el) |
| IL (1) | IL228319A (el) |
| ME (1) | ME02299B (el) |
| MX (1) | MX345264B (el) |
| MY (1) | MY162945A (el) |
| PL (1) | PL2687524T3 (el) |
| PT (1) | PT2687524E (el) |
| RS (1) | RS54377B1 (el) |
| RU (1) | RU2573634C2 (el) |
| SG (1) | SG193461A1 (el) |
| SI (1) | SI2687524T1 (el) |
| SM (1) | SMT201500319B (el) |
| TW (1) | TWI534142B (el) |
| WO (1) | WO2012124750A1 (el) |
| ZA (1) | ZA201307179B (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6020396B2 (ja) * | 2012-09-12 | 2016-11-02 | 大正製薬株式会社 | アゾール誘導体を含有する医薬 |
| JPWO2016136883A1 (ja) * | 2015-02-25 | 2017-12-07 | 大正製薬株式会社 | 発毛用外用組成物 |
| JP2017078044A (ja) * | 2015-10-21 | 2017-04-27 | 大正製薬株式会社 | 発毛剤組成物 |
| AU2020417293A1 (en) | 2020-01-03 | 2022-09-01 | Berg Llc | Polycyclic amides as UBE2K modulators for treating cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0159766B1 (ko) | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | 양모제 조성물 |
| EP0584223B1 (en) | 1991-05-09 | 1999-08-11 | Vertex Pharmaceuticals Incorporated | Novel immunosuppressive compounds |
| US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
| GB9804426D0 (en) | 1998-03-02 | 1998-04-29 | Pfizer Ltd | Heterocycles |
| WO1999062511A1 (en) | 1998-06-02 | 1999-12-09 | Bristol-Myers Squibb Company | Neurotrophic difluoroamide agents |
| JP2002516904A (ja) * | 1998-06-03 | 2002-06-11 | ジーピーアイ ニル ホールディングス インコーポレイテッド | Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド |
| KR20010052487A (ko) * | 1998-06-03 | 2001-06-25 | 쥐피아이 엔아이엘 홀딩스 인코포레이티드 | 신경계 질환 및 탈모 치료에 사용되는 아자-헤테로고리화합물 |
| GB9815696D0 (en) | 1998-07-20 | 1998-09-16 | Pfizer Ltd | Heterocyclics |
| US6228872B1 (en) | 1998-11-12 | 2001-05-08 | Bristol-Myers Squibb Company | Neurotrophic diamide and carbamate agents |
| MXPA02000330A (es) | 1999-07-09 | 2004-05-21 | Johnson & Johnson | Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados. |
| JP2001247569A (ja) | 1999-08-12 | 2001-09-11 | Japan Tobacco Inc | ピロリジン誘導体又はピペリジン誘導体及びその医薬用途 |
| US6818643B1 (en) | 1999-12-08 | 2004-11-16 | Bristol-Myers Squibb Company | Neurotrophic bicyclic diamides |
| JP4240978B2 (ja) * | 2002-09-30 | 2009-03-18 | 大正製薬株式会社 | アリールオキシメチルオキサジアゾール誘導体 |
| JP4221989B2 (ja) * | 2002-09-30 | 2009-02-12 | 大正製薬株式会社 | オキサジアゾール誘導体 |
| BRPI0717919A2 (pt) * | 2006-12-20 | 2013-11-05 | Taisho Pharmaceutical Co., Ltd | "agente profilático ou terapêutico para alopecia" |
-
2012
- 2012-03-14 TW TW101108668A patent/TWI534142B/zh not_active IP Right Cessation
- 2012-03-15 US US14/004,997 patent/US9181229B2/en not_active Expired - Fee Related
- 2012-03-15 WO PCT/JP2012/056624 patent/WO2012124750A1/ja active Application Filing
- 2012-03-15 SG SG2013069182A patent/SG193461A1/en unknown
- 2012-03-15 EP EP12757646.0A patent/EP2687524B1/en active Active
- 2012-03-15 HU HUE12757646A patent/HUE027055T2/en unknown
- 2012-03-15 JP JP2013504765A patent/JP5828339B2/ja not_active Expired - Fee Related
- 2012-03-15 PL PL12757646T patent/PL2687524T3/pl unknown
- 2012-03-15 MY MYPI2013701644A patent/MY162945A/en unknown
- 2012-03-15 SI SI201230334T patent/SI2687524T1/sl unknown
- 2012-03-15 KR KR1020137024653A patent/KR101854949B1/ko active IP Right Grant
- 2012-03-15 CN CN201280013162.8A patent/CN103502240B/zh not_active Expired - Fee Related
- 2012-03-15 MX MX2013010570A patent/MX345264B/es active IP Right Grant
- 2012-03-15 RS RS20150776A patent/RS54377B1/en unknown
- 2012-03-15 RU RU2013145886/04A patent/RU2573634C2/ru not_active IP Right Cessation
- 2012-03-15 PT PT127576460T patent/PT2687524E/pt unknown
- 2012-03-15 DK DK12757646.0T patent/DK2687524T3/en active
- 2012-03-15 AU AU2012229834A patent/AU2012229834B2/en not_active Ceased
- 2012-03-15 ES ES12757646.0T patent/ES2549559T3/es active Active
- 2012-03-15 CA CA2829746A patent/CA2829746C/en not_active Expired - Fee Related
- 2012-03-15 ME MEP-2015-201A patent/ME02299B/me unknown
- 2012-03-15 BR BR112013022710A patent/BR112013022710A2/pt active Search and Examination
-
2013
- 2013-09-09 IL IL228319A patent/IL228319A/en active IP Right Grant
- 2013-09-25 ZA ZA2013/07179A patent/ZA201307179B/en unknown
-
2014
- 2014-03-14 HK HK14102587.9A patent/HK1189580A1/zh not_active IP Right Cessation
-
2015
- 2015-10-06 HR HRP20151062TT patent/HRP20151062T1/hr unknown
- 2015-12-08 CY CY20151101118T patent/CY1117011T1/el unknown
- 2015-12-21 SM SM201500319T patent/SMT201500319B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120480T1 (el) | Ενωσεις πυραζολοπυριμιδινης | |
| CY1119422T1 (el) | Παραγωγα μπετουλινης | |
| CY1119731T1 (el) | Διαδικασια για την παρασκευη παραγωγων χολικου οξεος | |
| EA201290632A1 (ru) | Производные бетулина | |
| EA201590879A1 (ru) | Арилконденсированные и гетероарилконденсированные лактамы | |
| CY1118678T1 (el) | Παραγωγα καρβοξαμιδιου χλωρο-πυραζινης χρησιμα για την θεραπευτικη αντιμετωπιση ασθενειων που ευνοουνται απο την ανεπαρκη ενυδατωση του βλεννογονου | |
| EA201690094A1 (ru) | Ингибиторы syk | |
| EA201401054A1 (ru) | N-циклиламиды в качестве нематоцидов | |
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| CU24039B1 (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
| EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
| PH12014501417A1 (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
| EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
| EA201590319A1 (ru) | Новые бициклические пиридиноны | |
| EA201270752A1 (ru) | Ингибиторы киназы и способ лечения злокачественной опухоли с их помощью | |
| UA111626C2 (uk) | Похідні дигідрохінолін-2-ону | |
| EA201290800A1 (ru) | Гетероциклическое соединение | |
| EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
| EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
| EA201391056A1 (ru) | Гетероарильные соединения в качестве лигандов 5-htрецептора | |
| MX344933B (es) | Compuestos de lipoílo y su uso para tratar lesión isquémica. | |
| CY1117011T1 (el) | Παραγωγα αζολιου | |
| EA201491227A1 (ru) | Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2 |